These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17075155)

  • 1. Extensive drug-resistant TB: a threat for Europe?
    Manissero D; Fernandez de la Hoz K
    Euro Surveill; 2006 Sep; 11(9):E060928.2. PubMed ID: 17075155
    [No Abstract]   [Full Text] [Related]  

  • 2. Infectious disease. Drug-resistant TB on the rise.
    Stokstad E
    Science; 2000 Mar; 287(5462):2391. PubMed ID: 10766610
    [No Abstract]   [Full Text] [Related]  

  • 3. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiology of resistant tuberculosis in Europe.
    Rüsch-Gerdes S
    Infection; 1999; 27 Suppl 2():S17-8. PubMed ID: 10885821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical considerations to implement the shorter regimen to MDR-TB patients in China.
    Liu Q; Sun F; Li Y; Bao J; Zhang Y; Zhang W
    Clin Microbiol Infect; 2018 Oct; 24(10):1035-1036. PubMed ID: 29730223
    [No Abstract]   [Full Text] [Related]  

  • 6. A new treatment for drug-resistant tuberculosis in Ukraine.
    Holt E
    Lancet Infect Dis; 2022 Jan; 22(1):23. PubMed ID: 34953550
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
    Rando-Segura A; Aznar ML; Moreno MM; Espasa M; Sulleiro E; Bocanegra C; Gil E; Eugénio ANE; Escartin C; Zacarias A; Vegue J; Katimba D; Vivas MC; Gabriel E; Marina MC; Mendioroz J; López MT; Pumarola T; Molina I; Tórtola MT
    Emerg Infect Dis; 2018 Mar; 24(3):569-572. PubMed ID: 29460748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in TB regimen development: preserving evidentiary standards for regulatory decisions and policymaking.
    Guglielmetti L; Low M; McKenna L
    Expert Rev Anti Infect Ther; 2020 Aug; 18(8):701-704. PubMed ID: 32345064
    [No Abstract]   [Full Text] [Related]  

  • 9. The "source" of drug-resistant TB outbreaks.
    van Helden PD; Victor T; Warren RM
    Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-resistant tuberculosis: reality and potential threat.
    Lalloo UG
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610
    [No Abstract]   [Full Text] [Related]  

  • 11. Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope.
    Prasad R; Gupta N; Banka A
    Indian J Med Res; 2017 Sep; 146(3):301-303. PubMed ID: 29355135
    [No Abstract]   [Full Text] [Related]  

  • 12. Multidrug-resistant tuberculosis in Europe, 2010-2011.
    Günther G; van Leth F; Alexandru S; Altet N; Avsar K; Bang D; Barbuta R; Bothamley G; Ciobanu A; Crudu V; Davilovits M; Dedicoat M; Duarte R; Gualano G; Kunst H; de Lange W; Leimane V; Magis-Escurra C; McLaughlin AM; Muylle I; Polcová V; Pontali E; Popa C; Rumetshofer R; Skrahina A; Solodovnikova V; Spinu V; Tiberi S; Viiklepp P; Lange C;
    Emerg Infect Dis; 2015 Mar; 21(3):409-16. PubMed ID: 25693485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Shorter Treatment Regimen for Multidrug-resistant Tuberculosis feasible in Indian Children?
    Shah I
    Indian Pediatr; 2017 Feb; 54(2):160. PubMed ID: 28285296
    [No Abstract]   [Full Text] [Related]  

  • 14. The worldwide epidemic of multidrug-resistant tuberculosis.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2011 May; 11(5):333. PubMed ID: 21530885
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug-resistance in Mycobacterium tuberculosis in Castilla y León, Spain, 2001-2005: third collaborative study].
    Alberte-Castiñeiras A; Campos-Bueno A; López-Urrutia L; Alvarez-Alonso E; Megías G; Ojeda-Fernández E; López-Medrano R; Iglesias-García J; García-Carbajosa S; Pérez-Pascual P
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):706-9. PubMed ID: 20627375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis.
    Pérez-Lago L; Lirola MM; Navarro Y; Herranz M; Ruiz-Serrano MJ; Bouza E; García-de-Viedma D
    Emerg Infect Dis; 2015 Nov; 21(11):2098-100. PubMed ID: 26488258
    [No Abstract]   [Full Text] [Related]  

  • 17. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
    Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mycobacterium tuberculosis with extensive resistance].
    Labie D
    Med Sci (Paris); 2007 Feb; 23(2):205-9. PubMed ID: 17291432
    [No Abstract]   [Full Text] [Related]  

  • 19. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region].
    Mar'iandyshev AO; Nizovtseva NI; Glomozda PG; Panasik VP; Duginova TN; Kuznetsov AA
    Probl Tuberk Bolezn Legk; 2005; (5):19-21. PubMed ID: 15988972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired drug resistance because of pharmacokinetic variability in a young child with tuberculosis.
    Pasipanodya JG; Srivastava S; Gumbo T
    Pediatr Infect Dis J; 2014 Nov; 33(11):1205. PubMed ID: 25361414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.